7 Followers on Owler

Abbiotec

focuses on developing and commercializing next generation antibodies and reagents for the life science research community...
Read more

Abbiotec

focuses on developing and commercializing next generation antibodies and reagents for the life science research community...
Read more
Abbiotec President & CEO: Hervé Le Calvez

President & CEO

Hervé Le Calvez

CEO Approval Rating

87/100

Est. Annual Revenue
$25-100M
Agree?
Est. Employees
25-100
Agree?
Contacts
New
Schedule a Demo

Abbiotec Competitors

1
2
3
4
5
6
7
8
9
10

Abbiotec Headquarters

350 W. 9th Avenue Suite 107

Escondido, California92025

858-586-0500

Driving Directions »

Abbiotec Summary

ABOUT

Overview

Abbiotec focuses on developing and commercializing next generation antibodies and reagents for the life science research community. Abbiotec was founded in 2007. Abbiotec's headquarters is located in Escondido, California, USA 92025. Abbiotec's Presi...

CEO

Abbiotec's President & CEO, Hervé Le Calvez, currently has an approval rating of 87%. Abbiotec's primary competitors are Acris Antibodies, Abgent, Abide Therapeutics, Inc. and 7 more.

Acquisitions

There have been no acquisitions found related to Abbiotec

Funding

Funding data cannot be found related to Abbiotec

Investments

Recent investment data cannot be found related to Abbiotec

Frequently Asked Questions about Abbiotec

  1. When was Abbiotec founded?

    Abbiotec was founded in 2007
  2. Who is Abbiotec's CEO?

    Abbiotec's CEO is Hervé Le Calvez
  3. How much revenue does Abbiotec generate?

    Abbiotec generates $25M in revenue
  4. How much funding does Abbiotec have?

    Abbiotec has historically raised $0 in funding
  1. Where is Abbiotec's headquarters?

    Abbiotec's headquarters is in Escondido California, USA
  2. How many employees does Abbiotec have?

    Abbiotec has 60 employees
  3. What sector does Abbiotec operate in?

    Abbiotec is in Biotechnology
  4. Who are Abbiotec's competitors?

    Abbiotec's top competitors are Acris Antibodies, Abgent, Abide Therapeutics, Inc.

Trending Companies